Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins.

Yokota T, Meka CS, Medina KL, Igarashi H, Comp PC, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade PW.

J Clin Invest. 2002 May;109(10):1303-10.

2.

Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells.

Yokota T, Meka CS, Kouro T, Medina KL, Igarashi H, Takahashi M, Oritani K, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade PW.

J Immunol. 2003 Nov 15;171(10):5091-9.

4.
5.

Effect of prostaglandin E2 on recombinant human bone morphogenetic protein-2-stimulated osteoblastic differentiation in human periodontal ligament cells.

Takiguchi T, Kobayashi M, Nagashima C, Yamaguchi A, Nishihara T, Hasegawa K.

J Periodontal Res. 1999 Oct;34(7):431-6.

PMID:
10685373
6.

Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.

Choudhary S, Blackwell K, Voznesensky O, Deb Roy A, Pilbeam C.

Bone. 2013 Sep;56(1):31-41. doi: 10.1016/j.bone.2013.04.017. Epub 2013 Apr 29.

7.

Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells.

Harizi H, Juzan M, Grosset C, Rashedi M, Gualde N.

Cell Immunol. 2001 Apr 10;209(1):19-28.

PMID:
11414733
8.
9.

Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.

Yasumaru M, Tsuji S, Tsujii M, Irie T, Komori M, Kimura A, Nishida T, Kakiuchi Y, Kawai N, Murata H, Horimoto M, Sasaki Y, Hayashi N, Kawano S, Hori M.

Cancer Res. 2003 Oct 15;63(20):6726-34.

10.

Differential roles of insulin receptor substrates in brown adipocyte differentiation.

Tseng YH, Kriauciunas KM, Kokkotou E, Kahn CR.

Mol Cell Biol. 2004 Mar;24(5):1918-29.

11.
12.

Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells.

Harizi H, Norbert G.

Cell Immunol. 2004 Apr;228(2):99-109. Erratum in: Cell Immunol. 2004 Jun;229(2):159. Hedi, Harizi [corrected to Harizi, Hedi].

PMID:
15219461
13.
14.
15.

Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.

Koide M, Murase Y, Yamato K, Noguchi T, Okahashi N, Nishihara T.

Biochem Biophys Res Commun. 1999 May 27;259(1):97-102.

PMID:
10334922
16.

Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells.

Yan H, Kermouni A, Abdel-Hafez M, Lau DC.

J Lipid Res. 2003 Feb;44(2):424-9. Epub 2002 Nov 4.

17.
18.

Regulation of cyclooxygenase-2 pathway by HER2 receptor.

Vadlamudi R, Mandal M, Adam L, Steinbach G, Mendelsohn J, Kumar R.

Oncogene. 1999 Jan 14;18(2):305-14.

19.

Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins.

Xie Y, Kang X, Ackerman WE 4th, Belury MA, Koster C, Rovin BH, Landon MB, Kniss DA.

Diabetes Obes Metab. 2006 Jan;8(1):83-93.

PMID:
16367886
20.

Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.

Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.

Cancer Res. 2002 Nov 15;62(22):6706-11.

Supplemental Content

Support Center